Cara Therapeutics (CARA) Misses Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts CARA Hot Sheet
Join SI Premium – FREE
Cara Therapeutics (NASDAQ: CARA) reported Q4 EPS of ($0.43), $0.03 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- TSMC targets 2029 for panel-level CoPoS packaging in AI chip push - DigiTimes
- Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
